![Michael Huang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Huang
Director/Board Member at
ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED
Profile
Michael L.
Huang was the founder of Neurovive Pharmaceutical Asia, Inc., founded in 2014, where the title held was Chief Executive Officer from 2014 to 2017.
Current jobs include Director at Windgap Medical, Inc. since 2021, Director at Viracta Subsidiary, Inc. since 2019, Director at Regenacy Pharmaceuticals LLC, Director at Point Robotics Medtech, Inc., and Director at Elixiron Immunotherapeutics (Cayman) Ltd. since 2019.
Former jobs include Director at Sunesis Pharmaceuticals, Inc., Director at Fractyl Health, Inc., Independent Director at Frequency Therapeutics, Inc., Independent Director at Viracta Therapeutics, Inc. from 2019 to 2022, Director at Digestive Health Specialists PC, and Head-Investor Relations at TWi Pharmaceuticals, Inc. Education includes undergraduate studies at The University of Texas at Austin, graduate studies at The University of Texas at Arlington, and an MBA from Jones Graduate School of Business.
Michael Huang active positions
| Companies | Position | Start |
|---|---|---|
| ELIXIRON IMMUNOTHERAPEUTICS (CAYMAN) LIMITED | Director/Board Member | 25/07/2019 |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Director/Board Member | 01/01/2019 |
Regenacy Pharmaceuticals LLC
 Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors | Director/Board Member | - |
Point Robotics Medtech, Inc.
 Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Manufactures machinery and equipment products | Director/Board Member | - |
Windgap Medical, Inc.
 Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director/Board Member | 01/01/2021 |
Former positions of Michael Huang
| Companies | Position | End |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 23/08/2022 |
Digestive Health Specialists PC | Director/Board Member | 01/02/2022 |
Neurovive Pharmaceutical Asia, Inc. | Chief Executive Officer | 01/01/2017 |
| TWI PHARMACEUTICALS INC | Investor Relations Contact | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Michael Huang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Windgap Medical, Inc.
Windgap Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Arlington
 The University of Texas at Arlington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fractyl Health, Inc.
 Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity | Health Technology |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Viracta Subsidiary, Inc.
Viracta Subsidiary, Inc. BiotechnologyHealth Technology Develops proprietary viral gene activation therapy to address cancers associated with the epstein-barr virus | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
Regenacy Pharmaceuticals LLC
Regenacy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops novel treatments through regeneration of normal protein function using oral, isoform selective histone deacetylase enzyme inhibitors | Health Technology |
Point Robotics Medtech, Inc.
Point Robotics Medtech, Inc. Wholesale DistributorsDistribution Services Manufactures machinery and equipment products | Distribution Services |
Neurovive Pharmaceutical Asia, Inc. | |
Jones Graduate School of Business
 Jones Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
Elixiron Immunotherapeutics, Inc.
 Elixiron Immunotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision immunotherapy drugs | Health Technology |
Digestive Health Specialists PC |
- Stock Market
- Insiders
- Michael Huang
